Dimo Dimitrov, MD (@DimoDimitrovMD) header
Dimo Dimitrov, MD (@DimoDimitrovMD) profile picture

IM, PGY-3 at Boston Medical Center - Brighton, Boston. Passionate about and dedicated to Gastroenterology. 🇧🇬🇺🇸

Boston, Massachusetts
Joined May 2022
Photo by Dimo Dimitrov, MD (@DimoDimitrovMD)Photo by Dimo Dimitrov, MD (@DimoDimitrovMD)Photo by Dimo Dimitrov, MD (@DimoDimitrovMD)Photo by Dimo Dimitrov, MD (@DimoDimitrovMD)Photo by Dimo Dimitrov, MD (@DimoDimitrovMD)Photo by Dimo Dimitrov, MD (@DimoDimitrovMD)Photo by Dimo Dimitrov, MD (@DimoDimitrovMD)Photo by Dimo Dimitrov, MD (@DimoDimitrovMD)Photo by Dimo Dimitrov, MD (@DimoDimitrovMD)Photo by Dimo Dimitrov, MD (@DimoDimitrovMD)
Great start to @DDWMeeting 2026! Congrats to @JMelendezT on the oral presentations! Grateful to be part of this work and for the mentorship and support from @MetabolicEndo and colleagues at Brigham and Women’s Hospital.
2
7
465
Dimo Dimitrov, MD retweeted
📢 Excited to announce the 30th Annual Therapeutic Endoscopy Course, taking place February 26–28, 2027, in beautiful Park City, Utah! 🏔️ As Co-Director, alongside our outstanding colleagues, I am proud to help bring together Brigham and Women’s Hospital and the University of Utah School of Medicine for this milestone 30th anniversary course. 🎓 FELLOWS SCHOLARSHIPS AVAILABLE We are offering 30 scholarships of $1,250 each to GI fellows from across the country! The course features: 🔹 Video-based educational sessions 🔹 Multiple hands-on stations 🔹 Live endoscopy 🔹 Interactive breakout sessions with leading GI experts 🔹And of course, ample time for getting on the slopes in famous Park City 📅 February 25–28, 2027 📍 Sheraton Park City Resort | Park City, Utah 📝 Registration deadline: January 31, 2027. An outstanding opportunity for fellows to expand their knowledge, develop hands-on skills, and connect with leaders in therapeutic endoscopy! 📩 Questions / application: Lynsey Bell: [email protected] Feel free to contact me if needed for assistance or any questions.
🤖 Made with AI
9
27
1,256
Dimo Dimitrov, MD retweeted
📢 📰 Excited to share our latest clinical practice update in @GIE_Journal : 📚 “Role of Remimazolam in Gastrointestinal Endoscopy: American Society for Gastrointestinal Endoscopy Clinical Practice Update.” As part of the ASGE Standards of Practice Committee, I had the privilege of contributing to this document, which synthesizes the emerging evidence on remimazolam for procedural sedation in gastrointestinal endoscopy. 💡 Remimazolam represents an exciting advancement in endoscopic sedation, offering: 🔹 Rapid onset of action 🔹 Short duration of action 🔹 Organ-independent metabolism 🔹 A promising safety and efficacy profile Certainly not the holy grail of sedation, but offers an option for practicing GI docs. This clinical practice update reviews the evidence on efficacy, safety, dosing, and patient selection, with particular emphasis on optimizing sedation in higher-risk populations🎯 🙏 Grateful to Nirav Thosani, MD, MHA Jason Dominitz, MD, MHS, MASGE, AGAF, FACG, the ASGE Standards of Practice Committee, and all my co-authors for their collaboration and commitment to advancing gastrointestinal endoscopy. 🔗 Read the full publication: sciencedirect.com/science/ar…
1
6
33
1,403
Dimo Dimitrov, MD retweeted
It’s not really @AmCollegeGastro #ACG2026 @visitmusiccity if you don’t take this 📸 with my friend and mentee @DimoDimitrovMD !
1
26
830
Honored to receive both the Presidential Poster Award and Outstanding Poster Presenter Award at #ACG2026 for our work on endoscopic necrosectomy. Grateful to my mentors and coauthors for their support, and to @AmCollegeGastro for another fantastic meeting!
2
2
1
18
1,078
Dimo Dimitrov, MD retweeted
The Lab has grown, and I couldn’t be prouder of this incredible team! 🎉👏 From Presidential Poster and Outstanding Presenter Recognitions to oral presentations and top abstract awards in both interventional endoscopy and colon categories, our team continues to make meaningful contributions. Proud of our team’s dedication, hard work, and commitment to excellence. M🏆🔬 #ACG @AmCollegeGastro @WuLoneDragon @UtahGIFellows @KByrneGastroMD @UofUHealth
4
41
2,160
Dimo Dimitrov, MD retweeted
Portal hypertension is hard to teach with static diagrams. I’m building a simulator to explore how portal pressures and collateral flow change with disease and treatment. Work in progress. What scenario should it include? @LiverFellow @ebtapper #MedEd
13
88
1
508
22,040
The new Huberman Lab episode is out: Best Tools for Gut Health and Weight Loss | Dr. Chris Thompson 0:00 Dr. Chris Thompson 2:16 Digestive Tract, Gut Hormones & Nutrient Absorption 8:06 Colon Microbiome & Colon Cancer Screening 11:13 Sponsors: LMNT & Lingo 13:40 Swallowing Problems & Zenker's Diverticula 16:08 Bowel Movements & Constipation 18:28 Fiber, Resistant Starch & the Gut Barrier 21:50 Intermittent Fasting & the Gut Microbiome 23:38 Fermented Foods, Microbial Diversity & Butyrate 27:12 H. pylori, Stress & Stomach Ulcers 30:20 GLP-1 Medications: Benefits & Limitations 33:42 Lower GLP-1 Doses, Weight Regain & Muscle Loss 37:35 GLP-1 Side Effects, Food Noise & Apathy 39:49 Bariatric Surgery & Medical Innovation 46:07 Sponsor: AG1 47:44 Hunger & Satiety: Ghrelin, CCK, GIP & GLP-1 50:01 Retatrutide & Combining Hormonal Targets 52:55 Ultra-Processed Foods, Overeating & Leptin 55:32 Incretin Discovery, Exendin-4 & the Gila Monster 59:35 Endoscopic Ultrasound & Pancreatic Biopsy 1:07:40 Early Metabolic Markers, CGMs & Fasting Insulin 1:13:06 Insulin Resistance & Metabolic Flexibility 1:15:53 Sponsor: Function 1:17:35 Patient Data, Screening & Treatment Adoption 1:26:31 AI, Robotics & Improving Procedures 1:29:27 Choosing a Surgeon & Measuring Procedure Quality 1:35:29 Image Guidance & Hyperspectral Imaging 1:37:19 Sponsor: Our Place 1:38:56 Diagnostics & Targeted Metabolic Treatments 1:42:45 Gastric Bypass, Foregut Exclusion & Diabetes 1:47:59 Duodenal Liners & Mucosal Resurfacing Research 1:52:58 Gut Permeability, Inflammation & Fatty Liver 1:59:39 Artificial Sweeteners, Fructose, Fats & Omega-3s 2:05:00 Resistance Training, Zone 2 Cardio & Intervals 2:06:31 Weight Set Point & Metabolic Adaptation 2:08:13 Endoscopic Sleeve Gastroplasty & Fundus Ablation 2:10:30 Magnetic Intestinal Connections & Combined Treatments 2:16:52 GLP-1 Gene Therapy Research 2:22:13 Innovation, Problem Solving & Teamwork 2:25:58 Zero-Cost Support, Sponsors & Neural Network Newsletter Includes paid partnerships.
30
75
13
749
253,316
Dimo Dimitrov, MD retweeted
The gut is much more than a digestive organ. It is a metabolic sensing and signaling system that helps shape how we respond to food, regulate appetite, and control metabolism. Really enjoyed going deep on this with Andrew Huberman, from gut biology and the microbiome to obesity, GLP-1 therapies, and endoscopic treatments.
The new Huberman Lab episode is out: Best Tools for Gut Health and Weight Loss | Dr. Chris Thompson 0:00 Dr. Chris Thompson 2:16 Digestive Tract, Gut Hormones & Nutrient Absorption 8:06 Colon Microbiome & Colon Cancer Screening 11:13 Sponsors: LMNT & Lingo 13:40 Swallowing Problems & Zenker's Diverticula 16:08 Bowel Movements & Constipation 18:28 Fiber, Resistant Starch & the Gut Barrier 21:50 Intermittent Fasting & the Gut Microbiome 23:38 Fermented Foods, Microbial Diversity & Butyrate 27:12 H. pylori, Stress & Stomach Ulcers 30:20 GLP-1 Medications: Benefits & Limitations 33:42 Lower GLP-1 Doses, Weight Regain & Muscle Loss 37:35 GLP-1 Side Effects, Food Noise & Apathy 39:49 Bariatric Surgery & Medical Innovation 46:07 Sponsor: AG1 47:44 Hunger & Satiety: Ghrelin, CCK, GIP & GLP-1 50:01 Retatrutide & Combining Hormonal Targets 52:55 Ultra-Processed Foods, Overeating & Leptin 55:32 Incretin Discovery, Exendin-4 & the Gila Monster 59:35 Endoscopic Ultrasound & Pancreatic Biopsy 1:07:40 Early Metabolic Markers, CGMs & Fasting Insulin 1:13:06 Insulin Resistance & Metabolic Flexibility 1:15:53 Sponsor: Function 1:17:35 Patient Data, Screening & Treatment Adoption 1:26:31 AI, Robotics & Improving Procedures 1:29:27 Choosing a Surgeon & Measuring Procedure Quality 1:35:29 Image Guidance & Hyperspectral Imaging 1:37:19 Sponsor: Our Place 1:38:56 Diagnostics & Targeted Metabolic Treatments 1:42:45 Gastric Bypass, Foregut Exclusion & Diabetes 1:47:59 Duodenal Liners & Mucosal Resurfacing Research 1:52:58 Gut Permeability, Inflammation & Fatty Liver 1:59:39 Artificial Sweeteners, Fructose, Fats & Omega-3s 2:05:00 Resistance Training, Zone 2 Cardio & Intervals 2:06:31 Weight Set Point & Metabolic Adaptation 2:08:13 Endoscopic Sleeve Gastroplasty & Fundus Ablation 2:10:30 Magnetic Intestinal Connections & Combined Treatments 2:16:52 GLP-1 Gene Therapy Research 2:22:13 Innovation, Problem Solving & Teamwork 2:25:58 Zero-Cost Support, Sponsors & Neural Network Newsletter Includes paid partnerships.
2
29
4
127
50,835
Dimo Dimitrov, MD retweeted
iGIE article showcased on the Endoscopedia blog: "Zenker’s diverticulum in the era of third-space endoscopy: innovations, challenges, and adverse event management" by Dimo Dimitrov endoscopedia.com/2026/09/14/… @DimoDimitrovMD @DennisYangMD
3
2
274
Dimo Dimitrov, MD retweeted
In iNSIGHTS: Topic Review, Dimitrov et al explore "Zenker’s diverticulum in the era of third-space endoscopy: innovations, challenges, and adverse event management." igiejournal.org/article/S294… @DimoDimitrovMD @gutdoc18 @DiogoPhd @RakeshKalapala1 @SarahEnslinPA @ThomasRMcCarty3
1
2
149
Proud to share our @endoscopyjrnl publication comparing immediate vs step-up endoscopic necrosectomy for walled-off pancreatic necrosis. 📝 Deeply grateful to @DarylRamai for his trust, guidance, and support, and to all coauthors for all their hard work. thieme-connect.de/products/e…
1
8
2,149
Dimo Dimitrov, MD retweeted
📚 Two new publications, one shared goal: improving patient care after colorectal ESD! I'm excited to share 2 major studies showing that for benign lesions, surveillance can be safely extended 3 to 5 years! 📝 Study 1: Our international multicenter study demonstrates that extending surveillance colonoscopy to 3 years after curative ESD for non-malignant colorectal lesions is safe in appropriately selected patients *** Published in GUT - pubmed.ncbi.nlm.nih.gov/4242… 📊 Study 2: Our systematic review and meta-analysis confirms the excellent long-term outcomes after colorectal ESD, demonstrating low local recurrence rates following curative resection *** Published in Endoscopy - pubmed.ncbi.nlm.nih.gov/4211… 💡 Together, these studies support a more evidence-based, patient-centered approach to surveillance while helping reduce unnecessary procedures, 💵 and healthcare utilization. 🙏 A huge thank you to all of my co-authors @ThirdspaceEndo @JACQUESjer31657 @A_Qatomah Paul Brouzeng Marco Spadaccini Roberto de Sire @AzizullahBeran Ludovico Alfarone Veronique Van der Voort Geyl sophie @WuLoneDragon @thomas_rosch Thomas Rösch and others not on X. 🩺#Endoscopy #ESD @ESGE_news @ASGEendoscopy @AmCollegeGastro @UtahGIFellows @UofUHealth @KByrneGastroMD @HealioGastro
10
33
2,269
Thank you @videogie for allowing us to highlight our technique and why do we think it’s helpful in managing large colorectal lesion, one that we also use for gastric lesions as well!
Just posted on the official blog: "Multitraction point strategy for endoscopic submucosal dissection in managing difficult colorectal lesions" by Abdulrahman Qatomah endoscopedia.com/2026/07/17/… @a_qatomah
2
5
1,395
Dimo Dimitrov, MD retweeted
Grateful for the invitation to speak at the OESO 17th Annual International Conference 🇫🇷 Honored to join today’s surgical endoscopy session alongside some of the leaders and pioneers in the field.
1
22
876
Dimo Dimitrov, MD retweeted
Jirapinyo et al compare "Endoscopic versus surgical management of recurrent weight gain following sleeve gastrectomy." giejournal.org/article/S0016… #GITwitter @SighPichamol @MetabolicEndo
6
18
1,448
New publication in @videogie “Multitraction point (MTP) ESD strategy to manage difficult colorectal lesions” We’re able to show how to utilize multiple traction to facilitate resection of large colorectal lesions in a case series, take home messages: ✅ Lesion assessment and scope access 🎯 Choosing the correct sites for traction (including clip placement in the contra-lateral wall) is 🔑, to allow for maximum submucosal exposure, speedy yet safer dissection. 📌 Traction point removal using scissors to release one point and grasping to release second poiand extract the lesion. We found taht MTP found safe to use in the these cases, but more studies are needed! Proud to have performed all these cases solo under @ThirdspaceEndo supervision! @DarylRamai @ChrisChapmanMD 🔗 videogie.org/article/S2468-4…
2
8
1,379
Dimo Dimitrov, MD retweeted
Presented our international study on post ESD surveillance along with a panel of study speakers who are really pushing the field forward. ESGEdays 2026 was a blast! Thank you Cesare Hassan for this kind invitation 💙 Leaving feeling more energized than ever! @ESGE_news
5
30
1,051